![]() Epigenomics Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer. | ![]() Avacta Group Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics | ![]() Indi Molecular Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. | |
Founding Date | Founding Date 1998 | Founding Date 2003 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Berlin, DE HQ San Diego, US | Locations Wetherby, GB HQ London, GB Whittlesford, GB | Locations Culver City, US HQ |
Employees | Employees 329% decrease | Employees 154 | Employees 30 |
Valuation ($) | Valuation ($) 604.8 k | Valuation ($) 264.5 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) €24k (FY, 2025) | Revenue (est.) £6.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods £3.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €31k (FY, 2025) | Gross profit £3m (FY, 2025) | Gross profit N/A |
Net income | Net income (€314k) (FY, 2025) | Net income (£38.4m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 11.7m | Total funding raised N/A | Total funding raised $ 11.5m |

Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics
View company
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
View company